Supplemental material
Modern Rheumatology
Volume 28, 2018 - Issue 6
Open access
1,236
Views
3
CrossRef citations to date
0
Altmetric
Original Article
Efficacy and safety of sirukumab in Japanese patients with moderate to severe rheumatoid arthritis inadequately controlled by disease modifying anti-rheumatic drugs: Subgroup analysis of a phase 3 study
Tsutomu TakeuchiDivision of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan; View further author information
, Yoshiya TanakaFirst Department of Internal Medicine, School of Medicine, University of Occupational & Environmental Health Japan, Kitakyushu, Japan; View further author information
, Hisashi YamanakaInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan; View further author information
, Masayoshi HarigaiDepartment of Epidemiology and Pharmacoepidemiology, Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan; View further author information
, Toshikazu NakanoJanssen Pharmaceutical K.K., Tokyo, Japan; View further author information
, Koshiro AkagiJanssen Pharmaceutical K.K., Tokyo, Japan; View further author information
, Yoshifumi UkyoJanssen Pharmaceutical K.K., Tokyo, Japan; View further author information
& Benjamin HsuJanssen Research & Development, LLC, Spring House, PA, USACorrespondence[email protected]
View further author information
show allView further author information
Pages 941-949
|
Received 15 Nov 2017, Accepted 11 Jan 2018, Published online: 07 Feb 2018
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.